| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 19.098 | 290 | 500 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 19.099 | 290 | 500 | 17 | 11 | 9 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 275 | 320 | 270 | 290 | 209 | 210 | 184 | 121 | 120 |
| Gross Profit/Loss - EUR | - | 18.825 | -30 | 230 | -273 | -198 | -201 | -184 | -121 | -120 |
| Net Profit/Loss - EUR | - | 18.252 | -39 | 214 | -273 | -198 | -201 | -184 | -121 | -120 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Emped Study S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 18.586 | 495 | 924 | 793 | 870 | 670 | 622 | 602 | 600 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.956 | 0 | 500 | 7 | 6 | 6 | 6 | 6 | 6 |
| Cash | - | 15.630 | 495 | 424 | 787 | 864 | 664 | 616 | 596 | 594 |
| Shareholders Funds | - | 18.297 | 14 | 228 | -50 | -247 | -442 | -627 | -746 | -861 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 356 | 482 | 696 | 843 | 1.116 | 1.112 | 1.249 | 1.348 | 1.461 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Emped Study S.r.l.